The bcr-c-abl tyrosine kinase activity is extinguished by TPA in K562 leukemia cells.
Tyrosine kinase activity is associated with the transforming potential of several oncogenes. Human chronic myeloid leukemia (CML) cells and cell lines have been shown to contain an active bcr-c-abl p210 tyrosine kinase as a consequence of the Philadelphia chromosomal translocation. In the present work the activity of the c-abl and c-src oncogene-encoded tyrosine kinase was investigated during phorbol diester (TPA) induced differentiation of the K562 CML cells. The high tyrosine kinase activity of p210bcr-c-abl is strongly reduced during the initial 24 h of TPA treatment. In contrast, the activity of the c-src tyrosine kinase is not changed. No change occurs in the expression of the c-abl-specific RNAs during this period. Following the reduction of bcr-c-abl kinase activity, cell proliferation is arrested and megakaryoblastic antigens appear on the cells. Sodium butyrate caused a slight decrease in growth rate and of bcr-c-abl kinase activity during erythroid differentiation whereas no changes in c-src or c-abl tyrosine kinase activities were seen in DMSO-treated control cells.
D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D006801:Humans; D007122:Immunoelectrophoresis; D007700:Kinetics; D007951:Leukemia, Myeloid / Q000201:enzymology*; D009857:Oncogenes / Q000187:drug effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D011505:Protein-Tyrosine Kinases; D013755:Tetradecanoylphorbol Acetate